Page last updated: 2024-09-04

gadolinium dtpa and Pseudomyxoma Peritonei

gadolinium dtpa has been researched along with Pseudomyxoma Peritonei in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alzate, GD; Barone, RM; Lacey, C; Low, RN; Sebrechts, CP; Sigeti, JS1

Other Studies

1 other study(ies) available for gadolinium dtpa and Pseudomyxoma Peritonei

ArticleYear
Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Radiology, 1997, Volume: 204, Issue:2

    Topics: Administration, Oral; Barium Sulfate; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glucagon; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Peritoneal Neoplasms; Prospective Studies; Pseudomyxoma Peritonei; Sensitivity and Specificity; Tomography, X-Ray Computed

1997